Skip to content

Internet Buzz On Pfizer And Protalix BioTherapeutics’ Orphan Drug Elelyso For Gaucher Disease

December 10, 2012

        The Internet is buzzing about Protalix BioTherapeutics’ orphan drug Elelyso for Gaucher Disease : 

1)  ThePharmaLetter.com article titled, “Protalix and Pfizer expand Elelyso agreement”  

2)  Globes.co.il (Israel’s Business Arena) article titled, “Protalix signs $8.3 Milliion Pfizer deal for further Gaucher trials”  

3)  GlobalRegulatoryScience.com article titled, “Pfizer, Protalix near Elelyso supply deal in Brazil”  

4)  PubMed Citation: van Dussen L, Zimran A, Akkerman EM, Aerts JM, et al. Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease. Blood Cells Mol Dis. 2012 Nov 28 pii: S1079-9796(12)00197-0. doi: 10.1016/j.bcmd.2012.11.001. PMID: 23199589 [PubMed – as supplied by publisher].  

Copyright © 2012-2013, Orphan Druganaut Blog.  All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: